Copper Intravaginal Ring (Cu-IVR)
Development of prototypes of long- and short-acting versions of an innovative female-controlled, non-hormonal copper vaginal contraceptive method that may also reduce risk for acquisition of sexually transmitted infections and will be suitable for Phase I human clinical testing.
Development Stage:
Preclinical – Early (Pre1)
Hormonal/Non-Hormonal:
Non-Hormonal
Delivery Route & Method:
Intravaginal - Intravaginal Ring (IVR)
Mechanism of Action:
Inhibits sperm motility; antimicrobial properties against common sexually-transmitted pathogens
Developer:
- University of California, Davis
Funding:
- Nat. Institute Child Health & Human Development (NICHD)
Funding Mechanism:
NICHD: R61
Active Ingredient(s):
- Copper
Product Indication(s):
- HSV-2
- Pregnancy
- Zika virus (ZIKV)